GYPA and type 2 diabetes mellitus: Figure 2 illustrated the differences in circulating amount of CD235a+ PS+ RBC-derived vesicles in AF and non-AF patients with T2DM and HF depending on glycemia control, which were defined as HbA1c < 6.9 % and ≥7.0%.